Prof. Vatish commented: "We are delighted to be taking part in this important study which is crucial to help us understand both the safety and immunogenicity of the Pfizer-BioNTech vaccine for pregnant women and their children. We know that approved COVID-19 vaccines are safe for pregnant women as per JCVI guidance, but this will add valuable information to our knowledge of how these vaccines work".’’
Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.